1.48
0.00 (0.00%)
| Previous Close | 1.48 |
| Volume | 26,251 |
| Price / Sales | 2.22 |
| Price / Book | 0.590 |
| 52 Weeks Range |
| Operating Margin (TTM) | -19,230.14% |
| Diluted EPS (TTM) | -1.47 |
| Quarterly Revenue Growth (YOY) | -28.60% |
| Total Debt/Equity (MRQ) | 0.42% |
| Current Ratio (MRQ) | 2.24 |
| Operating Cash Flow (TTM) | -8.69 M |
| Levered Free Cash Flow (TTM) | -3.84 M |
| Return on Assets (TTM) | -54.16% |
| Return on Equity (TTM) | -117.16% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | BioRestorative Therapies, Inc. | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | -0.1 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -0.5 |
| Relative Valuation | NA |
| Financial Health | -0.3 |
| Macro Environment | -2.8 |
| AI Insight | NA |
| AI Technical | NA |
| Weighted Average | -0.19 |
Select this tab to load the latest available analysis.
|
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 25.54% |
| % Held by Institutions | 12.62% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Wealth Alliance, Llc | 30 Jun 2026 | 2,000 |
| Keystone Financial Group | 30 Jun 2026 | 1,430 |
No data within this time range.
No data within this time range.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |